Avidity Biosciences Inc RNA:NASDAQ

Last Price$24.92NASDAQ Previous Close - Last Trade as of 4:00PM ET 12/06/21
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$22.51 (1)
Ask (Size)$25.00 (5)
Day Low / HighN/A - N/A
Volume400.00
 

Read more news Recent News

Avidity Biosciences Says FDA Grants its AOC 1001 Myotonic Dystrophy Type 1 Treatment Fast-Track Designation
9:35AM ET 10/18/2021 MT Newswires

Avidity Biosciences (RNA) said the US Food and Drug Administration has granted fast-track designation to its lead program AOC 1001 to treat myotonic...

--Evercore ISI Starts Avidity Biosciences at Outperform with $50 Price Target
9:36AM ET 9/07/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Sector Update: Health Care Stocks Reverse Losses as Biotechs Rise
3:53PM ET 9/01/2021 MT Newswires

Health care stocks were ending near the flatline Wednesday, with the NYSE Health Care Index up less than 0.1% while the Health Care Select Sector SPDR ETF...

Top Midday Decliners
1:57PM ET 9/01/2021 MT Newswires

Support.com (SPRT) said independent proxy advisory firms Institutional Shareholder Services and Glass Lewis have endorsed its proposed merger with Bitcoin...

View all Commentary and Analysis

Avidity Biosciences (RNA) Corporate Presentation
4:15PM ET 9/10/2021 Seeking Alpha

Edgewise Therapeutics Proposes Terms For $150 Million IPO
5:48PM ET 3/23/2021 Seeking Alpha

Avidity Biosciences Has A Promising RNA Therapy Platform
9:07PM ET 1/12/2021 Seeking Alpha

Company Profile

Business Description
Number of EmployeesN/A
Recent SEC Filing11/22/20214

Company Highlights

Price Open$23.34
Previous Close$24.92
52 Week Range$17.58 - 36.02
Market Capitalization$1.2 B
Shares Outstanding46.9 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement03/21/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$2.45
Beta vs. S&P 500N/A
RevenueN/A
Net Profit Margin-995.69%
Return on Equity-30.60%

Analyst Ratings as of 09/03/2021

Buy
6
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset